PSEN2 and Alzheimer disease: Studies of familial AD patients, including APP, PSEN1, and PSEN2 mutation carriers, showed a significant negative correlation between serum NfLs and whole-brain and ventricular volume, both at baseline and longitudinally, and with hippocampal volume at baseline [53].